| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0022500 | Exon-Exon | chr3:172025153-172070873 | chr3:172307363-172353083 | 1734 nt | 0.5035 |
| hsa_FNDC3B_0022800 | Exon-Exon | chr3:172025232-172064230 | chr3:172307442-172346440 | 1224 nt | 0.4984 |
| hsa_FNDC3B_0022900 | Exon-Exon | chr3:172028618-172048505 | chr3:172310828-172330715 | 354 nt | 0.4887 |
| hsa_FNDC3B_0023100 | Exon-Exon | chr3:172028618-172050965 | chr3:172310828-172333175 | 141 nt | 0.3901 |
| hsa_FNDC3B_0023000 | Exon-Exon | chr3:172028618-172064230 | chr3:172310828-172346440 | 1164 nt | 0.4974 |
| hsa_chr3_0367900 | Intergenic-Intergenic | chr3:172028622-172070722 | chr3:172310832-172352932 | 330 nt | 0.5030 |
| hsa_chr3_0368000 | Intergenic-Intergenic | chr3:172030548-172032618 | chr3:172312758-172314828 | 2071 nt | 0.4442 |
| hsa_FNDC3B_0023200 | Intron-Intron | chr3:172034027-172037942 | chr3:172316237-172320152 | 250 nt | 0.4400 |
| hsa_chr3_0368100 | Intergenic-Intergenic | chr3:172044751-172045044 | chr3:172326961-172327254 | 294 nt | 0.4558 |
| hsa_FNDC3B_0023400 | Exon-Exon | chr3:172046742-172048505 | chr3:172328952-172330715 | 300 nt | 0.5000 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].